Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zillow, Inc. (“Zillow” or the “Company”) (NASDAQ: Z). Such investors are...
-
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS). Such investors are...
-
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NYSE: AZN). Such investors are advised...
-
SPOKANE, Wash., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Avista Corp.’s (NYSE: AVA) board of directors has declared a quarterly dividend of $0.4925 per share on the company’s common stock, yielding an...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Coastal (CCB) To Contact Him Directly To Discuss Their Options If you purchased or...
-
PHX Energy Announces Highest Second Quarter Revenue in its History and Continued Record RSS Activity
CALGARY, Alberta, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Second Quarter Highlights For the three-month period ended June 30, 2026, PHX Energy generated consolidated revenue of $178.9 million, which is...
-
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are...
-
Las Vegas, NV, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Wonderballs, a men’s apparel brand focused on men’s health, comfort, material transparency, and everyday essentials, launches a National Underwear...
-
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX). Such investors...
-
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ:...